Back to Search Results.

Frank L. Meyskens, Jr.
Positions:
Professor of Medicine, Biological Chemistry and Public Health, College of Health Sciences
School of Medicine

Director, Chao Family Comprehensive Cancer Center, University of California Irvine


Degree:
M.D., University of California, San Francisco, 1972
Research
Interests:
Melanoma, chemoprevention, polyamines.
Research
Abstract:
We are studying the basis of drug resistance of melanoma cells with a particular interest in Ref-1/APE and redox regulation. We have also proposed an alternative model for the etiology and progression of cutaneous melanoma based on the altered redox metabolism in human melanoma cells and developed new anticancer therapies based on these observations.

We are heavily involved in Phase I, II, and III clinical chemoprevention trials involving oral, colon, pancreas cancer, and melanoma and study such compounds as difluromethiornithine, Bowman-Birk Inhibitors (a Soybean-derived compound) SAMe, and Lovastatin.
Publications:
Research and Symposium: Gerner E.W., Meyskens F.L., Jr. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res. 2009 Feb 1;15(3):758-61. Review McEligot, A.J., Yang, S., Meyskens, F.L., Jr. Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu. Rev. Nutr. 25:261-95, 2005
 
Peer Review: Yang, Z., Yang, S., Minser, B.J., Chiu, R., Liu, F., Meyskens, F.L., Jr. Nitric oxide initiates progression of human melanoma via a feedback loop medited by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol Cancer Ther. 2008 Dec;7(12):3751-60. Meyskens, F.L., Jr., McLaren, C.E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P., Hawk, E., Kelloff, G., Lawson, M.J., Kidao, J., McCracken, J., Albers, C.G., Ahnan, D.J., Turgeon, D.K., Goldschmid, S., Lanoe, P., Hagedorn, C.H., Gillan, D.L., Gerner, E.W.: Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A randomized placebo-controlled, Double-Blind Trial. Cancer Prev Res June 1:15-32, 2008
 
Editorials: Meyskens, F.L., Jr., Berwick, M. UV or not UV?: Metals, the Answer. Cancer Epi. Biom. Prev. 2008, Feb 17:268-270. Meyskens, F.L., Jr., Ransohoff, D.F. Predicting Risk for the Appearance of Melanoma. Journal of Clinical Oncology 24: 3522-3533, 2006.
Address
University of California
Bldg 23 - Rt 81
101 The City Drive
Mail Code: 2675
Orange, CA 92868
Phone:
(714) 456-6310
Fax:
(714) 456-2240
Email:
flmeyske@uci.edu
URL
www.ucihs.uci.edu/biochem/faculty/meyskens.html
Updated 04/20/2010

Copyright (c) Regents of the University of California, 1997. All rights reserved. Technical problems or comments to: webmaster Last update: f_profile.last_updt_dt